Status:
COMPLETED
Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa
Lead Sponsor:
Azienda Policlinico Umberto I
Conditions:
Retinitis Pigmentosa
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Our aim was to assess the role and usefulness of Hyperbaric oxygen therapy in a long lasting period, assessing its efficacy on rescuing retinal photoreceptors and preserving visual function in retinit...
Eligibility Criteria
Inclusion
- Patients with clearly hereditary RP (we performed to all of them genetic analysis for rhodopsin, and peripherin genes, only 4 patient with ADRP showed point mutation 3 on codon 135 and 1 on codon 347); best corrected visual acuity (BCVA) ≥ 0.50 logMAR; visual field ≥ 3 degree diameter circle; recordable ERG.
Exclusion
- Exclusion criteria were: patients with sporadic RP; BCVA ≤ 0.50 logMAR; visual field ≤ 3 degree diameter circle; not recordable ERG.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00461435
Last Update
April 18 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Policlinico Umberto I
Rome, Italy, 00161